RenovoRx, Inc.
RNXT
$0.85
-$0.02-2.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.71% | -21.19% | -31.44% | -26.17% | 13.86% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 174.45% | 190.31% | 219.80% | 103.83% | 6.34% |
| Change in Net Operating Assets | -188.21% | -6,237.50% | -140.69% | -196.90% | -53.72% |
| Cash from Operations | -20.25% | -18.69% | -11.04% | -5.60% | 11.05% |
| Capital Expenditure | 83.33% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 83.33% | -- | -- | -- | -100.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.01% | -4.48% | -12.91% | 118.20% | 246.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 41.80% | -- | -- | -- | -- |
| Cash from Financing | -28.26% | -27.89% | -27.72% | 96.79% | 201.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.17% | -92.41% | -90.12% | 1,430.48% | 285.86% |